Advancing age and the risk of nasal carriage of Staphylococcus aureus among patients on long-term hospital-based hemodialysis

Annals of Saudi Medicine

Volumn 24, Issue 5, 2004, Pages 337-342

  Saxena, Anil K ^a   Panhotra, B R ^a   Chopra, Rajan ^a  

^a KING FAHAD HOSPITAL   (Saudi Arabia)

Author keywords

End stage renal disease; Hemodialysis; Methicillin resistant Staphylococcus aureus; Saudi Arabia; Septicemia

Indexed keywords

METICILLIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; INFECTION RISK; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE SMEAR; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTICEMIA; STANDARDIZATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UPPER RESPIRATORY TRACT INFECTION; VASCULAR ACCESS;

EID: 5744243867     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2004.337     Document Type: Article

References (34)

1. Vanholder R, Biesen WV. Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif. 2002;20:477-480.
2. U.S. Renal Data System: U.S. Renal Data System. Annual report.1999; Chapter IX: 131-143.
3. Nielsen J, Ladefoged S, Kolmos H. Dialysis Catheter-related septicemia: Focus on Staphylococcus aureus septicemia. Nephrol Dial Transplant. 1998;13: 2847-2852.
4. Saxena AK, Panhotra BR, Naguib M et al. Septicemia in hemodialysis : A focus on bacterial flora and antibiotic access salvage. Saudi J Kidney Dis Transplant. 2002;13:29-34.
5. Goldblum SE, Reed WP, Ulrich JA, Goldman RS. Staphylococcus aureus nasal carriage and infections in hemodialysis patients. Dial Transplant. 1978;7:1140-1163.
6. Yu VL, Goetz A, Wagner M et al. Staphylococcus aureus nasal carriage and infections in patients on hemodialysis. N Engl J Med. 1986;315:91-96.
7. Aly R, Maibach HI, Strauss WG, Shinefield HR. Effects of systemic antibiotics on nasal bacterial etiology in man. Appl Microbiol. 1970; 20: 240-244.
8. Sims RJA, Cassidy MJD, Masud T. The increasing number of older patients with renal disease. BMJ. 2003; 327:463-464.
9. Ansell D, Feest T, Byrne C. UK Renal Registry Report 2002. UK Renal Registry, Bristol, UK.
10. Centers for Disease Control (CDC) and Prevention Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR. 2001;50:1-43.
11. Geert JA W, Peter M S, Annielies B, Egidia VG, Marrianne IK. Optimizing screening procedures for Staphylococcus aureus nasal carriage in patients on hemodialysis. Nephrol Dial Transplant. 1998;13: 1256-1258.
12. Alghaithy AA, Bilal NE, Gedebou M, Weily AH. Nasal carriage and antibiotic resistance of Staphylococcus aureus isolates from hospital and non-hospital personnel in Abha, Saudi Arabia. Trans R Soc Trop Med Hyg. 2000;94:504-507.
13. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG. Prospective study of microbial colonization of nose and skin and infection of vascular access site in hemodialysis patients. J Clin Microbiol. 1988; 26:1257-1262.
14. O'Sullivan NP, Keane CT. The prevalence of methicillin resistant Staphylococcus aureus among the residents of six nursing homes for the elderly. J Hosp Infect. 2000;45:322-329
15. Parnaby RM, O'Dwyer CT. The prevalence of methicillin resistant Staphylococcus aureus in elderly. J Hosp Infect. 1996;33:201-106.
16. Descamps-Latscha B, Drüeke T, Witko-Sarsat V. Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy. Semin Dial. 2001; 14:193-199
17. Hirokawa K, Utsuyama M, Kasai M et al. Aging and immunity. Acta Pathol Jpn. 1992;42:537-548.
18. Lesourd B, Mazari L. Nutrition and immunity in the elderly. Proc Nutr Soc. 1999;58:685-695.
19. Pecoits-Filho R, Landholm B, Stenvinkel P. The malnutrition, inflammation and atherosclerosis (MIA) syndrome. Nephrol Dial Transplant. 2002;17:28-31.
20. Descamps-Latscha B, Jungers P, Witko-Sarat V. Immune syatem dysregulation in uremia: Role of oxidative stress. Blood Purif. 2002;20:481-484.
21. Meier P, Payer E, Blanc E et al. Early T-cell activation correlation with expression of apoptosis markers in patients with end stage renal disease. J Am Soc Nephrol. 2002;13:204-212.
22. Lee LY, Miyamoto YJ, McIntyre BW, et al. The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. J Clin Invest. 2002; 110:1461-1471.
23. Von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001;344:11-16.
24. Foster TJ, McDevitt D. Surface-associated proteins of Staphylococcus aureus: their possible roles in virulence. FEMS Microbiol. 1994;118:199-205.
25. Patti JM, Allen BL, McGavin MJ, Höök M. MSCRAMM-mediated adherence of microorganisms to host tissues. Ann Rev Microbiol. 1994;48:585-617.
26. Lowy FD. Staphylococcus aureus infections. N Eng J Med. 1998;339:520-532.
27. Besarab A, Adams M, Amatucci S et al. Unraveling the realities of vascular access: the network 11 experience. Adv Ren Replace Ther. 2000;7:65-70.
28. Saxena AK, Panhotra BR, Uzzaman W, Venkateshappa CK. The role of Staphylococcus aureusnasal carriage and type of vascular access in the outcome of high-risk patients on hemodialysis. J Vasc Access. 2002;3:74-79.
29. Saxena AK, Panhotra BR. The impact of nasal carriage of Staphylococcus aureus on the type of vascular access and dialysis access related septicemia in elderly. Dial Transplant. 2003;32:61-70.
30. Watanabe H, Masaki H, Asoh N, Watanabe K, Oishi K, Furumoto A. Emergence and spread of low-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from a community hospital in Japan. J Hosp Infect. 2001; 47: 294-300.
31. Morton TM, Johnston JL, Patterson G, Archer GL. Characterization on a conjugative staphylococcal mupirocin resistance plasmid. Antimicrob Agents Chemother. 1995;39:1272-1280
32. Shinefield H, Black S, Fattom A et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Eng J Med. 2002;346:491-496.
33. NKF-DOQI. Clinical Practice Guidelines for vascular access. New York: National Kidney Foundation; 1997: 3: 22-23.
34. Saxena AK, Panhotra BR, Naguib M et al. The impact of achieving goal for AV fistula set by NKF-DOQI, on Staphylococcus aureus septicemia. Dial Transplant. 2002;31:16-23.